Skip to main content
. 2020 Nov 6;11(11):953. doi: 10.1038/s41419-020-03160-y

Fig. 4. miR-185-5p participates in the regulation of p66Shc expression.

Fig. 4

a miR-185-5p has a predicted binding site in p66Shc from humans and mice. b Liver miR-185-5p expression, n = 6. c Hepatocytes miR-185-5p expression, n = 6. *p < 0.05, **p < 0.01 vs. the control group. d, e AML12 cells were transfected with agomir-NC or miR-185-5p agomir. d miR-185-5p expression, n = 6. e p66Shc protein, n = 3. **p < 0.01 vs. the ago-NC group. f, g AML12 cells were transfected with antagomir-NC or miR-185-5p antagomir. f miR-185-5p expression, n = 6. g p66Shc protein, n = 3. **p < 0.01 vs. the ant-NC group. h AML12 cells were transfected with wild-type or mutant SHC1-3′-UTR luciferase constructs and with agomir-NC or miR-185-5p agomir. Luciferase activity was detected 48 h after transfection. **p < 0.01 vs. the ago-NC group.